News
NSF-funded Smartphone COVID-19 Diagnostic Test Could Put Testing in...
A smartphone diagnostic test for COVID-19 being developed by a University of Utah researcher holds the potential for quick, accurate testing without the need for...
News
BMS Research at ASCO Demonstrates Diverse Approaches in Treating...
Bristol Myers Squibb announced the presentation of data across its portfolio, aimed at addressing solid tumor and hematologic malignancies in 28 types of cancer, at...
News
HCATS, Apceth Expand Manufacturing Pact with Bluebird Bio
Hitachi Chemical Advanced Therapeutics Solutions, LLC (HCATS) and apceth Biopharma GmbH (apceth), have expanded their relationship with bluebird bio with long-term development and manufacturing services...
News
Thermo Fisher Scientific Announces SARS-CoV-2 GlobalAccess Sequencing Program
To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific announces the SARS-CoV-2 GlobalAccess Sequencing Program for research consortia...
News
FDA Approves Eli Lilly Precision Oncology Treatment for Certain...
Eli Lilly is moving quickly to get a newly-approved precision oncology treatment for certain lung and thyroid cancers into the hands of patients.
Following U.S. Food...
News
Enhertu granted Breakthrough Therapy Designation in the US for...
AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment of...
News
Novavax to Receive up to $388 Million Funding from...
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the Coalition for Epidemic Preparedness Innovations (CEPI) will invest up...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.